Gain TherapeuticsGANX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 28 institutions reported holding Gain Therapeutics Inc. (GANX) in their 13F filings, up 2 from Q1 2024. 8 opened new positions and 6 sold out. The largest holders were Timelo Investment Management Inc. ($775K), Greenlight Capital (DME Capital Management) ($725K) and Alyeska Investment Group, L.P. ($576K). 3 famous investors held it, including David Einhorn (0.0% of Greenlight Capital (DME Capital Management)'s portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Gain Therapeutics Inc.
- CUSIP
- 36269B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $2.1M |
| Exits | 6 | $1.2M |
All 13F filers, Q1 2024 → Q2 2024: 1,762,338 shares bought and 593,072 shares sold, net +1,169,266 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Timelo Investment Management Inc. | 1.56% | New | 605,288 | $775K |
| Greenlight Capital (DME Capital Management) | 0.04% | No change | 566,130 | $725K |
| Alyeska Investment Group, L.P. | 0.00% | New | 450,000 | $576K |
| Hohimer Wealth Management, LLC | 0.10% | New | 330,000 | $422K |
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 183,736 | $235K |
| Vanguard Group Inc. | 0.00% | Add +21.7% | 145,217 | $186K |
| Cable Car Capital, LP | 0.20% | New | 145,000 | $186K |
| Renaissance Technologies | 0.00% | Add +154.2% | 118,700 | $152K |
| CM Management, LLC | 0.11% | No change | 90,000 | $115K |
| BlackRock Inc. | 0.00% | Add +12.2% | 84,620 | $108K |
| Warberg Asset Management LLC | 0.31% | New | 51,600 | $66K |
| Northern Trust Corp. | 0.00% | Reduce -3.3% | 44,944 | $58K |
| Bridgeway Capital Management, LLC | 0.00% | Add +33.3% | 40,000 | $51K |
| Prelude Capital Management, LLC | 0.00% | No change | 35,820 | $46K |
| State Street Corp. | 0.00% | Add +11.7% | 34,437 | $44K |
| Virtu Financial LLC | 0.00% | New | 27,356 | $35K |
| Millennium Management | 0.00% | Reduce -47.4% | 23,373 | $30K |
| UBS Group AG | 0.00% | Add +31.7% | 11,422 | $15K |
| Gilbert & Cook, Inc. | 0.00% | New | 10,000 | $13K |
| Simplex Trading, LLC | 0.00% | Reduce -49.6% | 9,059 | $11K |
| Group One Trading LLC | 0.00% | Add +269.9% | 7,401 | $9K |
| Jones Financial Companies LLLP | 0.00% | New | 7,000 | $9K |
| Creekmur Asset Management LLC | 0.00% | No change | 4,440 | $6K |
| Bank of America Corp. | 0.00% | Add +3.7% | 3,500 | $4K |
| Morgan Stanley | 0.00% | Add +17.9% | 3,300 | $4K |
| Wells Fargo & Company | 0.00% | Reduce -29.4% | 2,650 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -62.7% | 1,729 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -99.9% | 159 | $0 |
"% of holder's portfolio" is GANX's weight in each manager's 13F, not the share of Gain Therapeutics Inc. the manager owns.